We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $172M
1-Year Est. Return 21.18%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+21.18%
3 Year Est. Return
+55.24%
5 Year Est. Return
+52.07%
10 Year Est. Return
+229.25%
AUM
$175M
AUM Growth
+$10.3M
Cap. Flow
-$618K
Cap. Flow %
-0.35%
Top 10 Hldgs %
50.43%
Holding
283
New
14
Increased
15
Reduced
52
Closed
24

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$5.01M
2
FDX icon
FedEx
FDX
+$4.98M
3
GILD icon
Gilead Sciences
GILD
+$3.35M
4
AMP icon
Ameriprise Financial
AMP
+$1.07M
5
A icon
Agilent Technologies
A
+$605K

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$5.74M
2
UL icon
Unilever
UL
+$2.41M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.71M
4
CVX icon
Chevron
CVX
+$717K
5
JPM icon
JPMorgan Chase
JPM
+$597K

Sector Composition

Rank Sector Weight
1 Healthcare 32.27%
2 Technology 14.47%
3 Industrials 13.67%
4 Communication Services 11.16%
5 Financials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CC icon
226
Chemours
CC
$2.48B
$6K ﹤0.01%
150
– –
CRM icon
227
Salesforce
CRM
$154B
$6K ﹤0.01%
35
– –
HPQ icon
228
HP
HPQ
$26B
$6K ﹤0.01%
250
– –
PSX icon
229
Phillips 66
PSX
$82.9B
$6K ﹤0.01%
50
– –
AIG icon
230
American International
AIG
$42.5B
$5K ﹤0.01%
100
– –
LITE icon
231
Lumentum
LITE
$46.9B
$5K ﹤0.01%
+80
New +$4.79K
NVO
232
Novo Nordisk
NVO
$228B
$5K ﹤0.01%
200
– –
NXPI icon
233
NXP Semiconductors
NXPI
$60.8B
$5K ﹤0.01%
+61
New +$5.85K
OUT icon
234
Outfront Media
OUT
$5.75B
$5K ﹤0.01%
254
– –
VIAV icon
235
Viavi Solutions
VIAV
$7.95B
$5K ﹤0.01%
+400
New +$4.32K
JCI icon
236
Johnson Controls International
JCI
$85.1B
$4K ﹤0.01%
125
-200
-62% -$7.37K
MZTI
237
The Marzetti Company
MZTI
$3.05B
$4K ﹤0.01%
30
– –
MET icon
238
MetLife
MET
$62.4B
$4K ﹤0.01%
96
– –
NGG icon
239
National Grid
NGG
$79.3B
$4K ﹤0.01%
89
– –
RYAAY icon
240
Ryanair
RYAAY
$30B
$4K ﹤0.01%
98
– –
SNY icon
241
Sanofi
SNY
$107B
$4K ﹤0.01%
100
– –
EFA icon
242
iShares MSCI EAFE ETF
EFA
$76.4B
$3K ﹤0.01%
40
– –
KEY icon
243
KeyCorp
KEY
$23.8B
$3K ﹤0.01%
136
– –
TRST
244
Trustco Bank Corp NY
TRST
$953M
$3K ﹤0.01%
71
– –
VIVO
245
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
200
– –
RDC
246
DELISTED
Rowan Companies Plc
RDC
$3K ﹤0.01%
140
– –
DXC icon
247
DXC Technology
DXC
$1.91B
$2K ﹤0.01%
25
– –
IJT icon
248
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
$2K ﹤0.01%
20
– –
PBW icon
249
Invesco WilderHill Clean Energy ETF
PBW
$379M
$2K ﹤0.01%
100
– –
BBBY
250
DELISTED
Bed Bath & Beyond Inc
BBBY
$2K ﹤0.01%
150
– –
8 9
10
11 12

Similar funds

CRFG
Columbia River Financial Group Vancouver, Washington $172M AUM 13.74% 1-Year Est. Return
TA
Tiptree Advisors New York $172M AUM 86.65% 1-Year Est. Return
BIA
Benchmark Investment Advisors Chicago, Illinois $172M AUM
GWCM
Godshalk Welsh Capital Management Radnor, Pennsylvania $172M AUM 16.03% 1-Year Est. Return
PWM
Peterson Wealth Management Sparks, Nevada $172M AUM 22.85% 1-Year Est. Return
SPF
South Plains Financial Lubbock, Texas $172M AUM 21.06% 1-Year Est. Return
AIG
Abbington Investment Group Westport, Connecticut $172M AUM
BAM
Bullseye Asset Management Denver, Colorado $173M AUM 9.48% 1-Year Est. Return

Prentiss Smith & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Prentiss Smith & Co held 283 positions worth $175M, up 6.2% from $165M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Prentiss Smith & Co's Q3 2018 filing shows 14 new, 15 increased, 52 reduced and 24 closed positions. Its largest new stake was abrdn Physical Gold Shares ETF: 9,300 shares worth $107K. The largest sale was Oracle, an estimated $5.74M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Prentiss Smith & Co's largest Q3 2018 buy was abrdn Physical Gold Shares ETF: 9,300 shares worth $107K.
  • Prentiss Smith & Co added most to State Street in Q3 2018, an estimated $5.01M increase.
  • Prentiss Smith & Co's biggest Q3 2018 reduction was Oracle, cutting an estimated $5.74M.
  • Prentiss Smith & Co fully exited Foundation Medicine, Inc. in Q3 2018, selling an estimated $490K.
  • Prentiss Smith & Co's ten largest holdings make up 50% of its $175M portfolio in Q3 2018.
  • Prentiss Smith & Co opened 14 new positions and closed 24 in Q3 2018.
  • Prentiss Smith & Co's portfolio value rose 6.2% quarter-over-quarter to $175M.

Based on Prentiss Smith & Co's 13F filing for Q3 2018, filed 23 Oct 2018.